ReviewFrontiers in oncology2020

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.

Marcin Nicoś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.